135 related articles for article (PubMed ID: 11269741)
21. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.
Iwai K; Maeda H; Konno T
Cancer Res; 1984 May; 44(5):2115-21. PubMed ID: 6324996
[TBL] [Abstract][Full Text] [Related]
22. [Enhanced effect of hepatic arterial infusion of anticancer drugs of rabbit VX-2 hepatic implants].
Koyama Y; Hoshino M; Ono T; Inoue N; Tsuchiya A; Abe R
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1721-4. PubMed ID: 2167643
[TBL] [Abstract][Full Text] [Related]
23. [Prevention of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein].
Yamasaki K; Konno T; Miyauchi Y; Maeda H
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1224-8. PubMed ID: 3034169
[TBL] [Abstract][Full Text] [Related]
24. [Experimental studies on the dynamics of anticancer agents in transcatheter arterial chemo-embolization. Magnetic resonance imaging using emulsions containing lipiodol and Gd-DTPA].
Ishio M
Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):285-95. PubMed ID: 1652593
[TBL] [Abstract][Full Text] [Related]
25. [Hepatic parenchymal changes after intraarterial administration of lipiodol: an animal experiment].
Akashi Y; Koreeda C; Enomoto S; Nishimura T; Tateiwa J; Mizuno T; Inoue K; Koreeda T; Ha-Kawa SK
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Mar; 51(3):289-91. PubMed ID: 1646441
[TBL] [Abstract][Full Text] [Related]
26. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
Konno T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275
[TBL] [Abstract][Full Text] [Related]
27. Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver.
Iwai K; Maeda H; Konno T; Matsumura Y; Yamashita R; Yamasaki K; Hirayama S; Miyauchi Y
Anticancer Res; 1987; 7(3 Pt B):321-7. PubMed ID: 2820293
[TBL] [Abstract][Full Text] [Related]
28. [Effect of percutaneous intratumoral injection of lipiodol emulsion of chemotherapie agents on implanted VX2 tumor in rabbits].
Song JW; Li YH; Chen Y; Yang Y; Liu XH; Ning JJ; Yang J; Shi XX
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Nov; 30(11):2526-9. PubMed ID: 21097424
[TBL] [Abstract][Full Text] [Related]
29. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
Ohtsuka N; Konno T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992
[TBL] [Abstract][Full Text] [Related]
30. [Targeted chemotherapy of hepatocellular carcinoma using Lipiodol as a carrier].
Konno T; Oda T; Nagamitsu A; Tabaru K; Yamashita R; Kai Y
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1392-9. PubMed ID: 8854762
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of carcinomatous effusion with oily anticancer agents dissolved in lipiodol].
Kimura M; Konno T; Oda T; Yamashita R
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1579-82. PubMed ID: 2167635
[TBL] [Abstract][Full Text] [Related]
32. [Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent].
Oda T; Konno T; Ohtsuka N; Kimura M; Mizumachi R
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2423-8. PubMed ID: 1835341
[TBL] [Abstract][Full Text] [Related]
33. The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.
Jae HJ; Chung JW; Park HS; Lee MJ; Lee KC; Kim HC; Yoon JH; Chung H; Park JH
Korean J Radiol; 2009; 10(6):596-603. PubMed ID: 19885316
[TBL] [Abstract][Full Text] [Related]
34. [The effects of lipiodol-hydroxyapatite nanoparticle on apoptosis, proliferation, and angiogenesis in hepatic tumor: experiment with rabbits].
Sun ZG; Chen XP; Huang ZY; Yang GH; Guan J; Hu DY; Mu LD; Xia XG; Li GP; Zhang WG; Li Z
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):409-13. PubMed ID: 17456384
[TBL] [Abstract][Full Text] [Related]
35. Intracavitary treatment of malignant ascitic carcinomatosis with oily anticancer agents in rats.
Kimura M; Konno T; Oda T; Maeda H; Miyauchi Y
Anticancer Res; 1993; 13(5A):1287-92. PubMed ID: 8239499
[TBL] [Abstract][Full Text] [Related]
36. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats.
Hanada M; Baba A; Tsutsumishita Y; Noguchi T; Yamaoka T
Cancer Sci; 2009 Jan; 100(1):189-94. PubMed ID: 19037997
[TBL] [Abstract][Full Text] [Related]
37. [Intra-hepatic artery infusional chemotherapy with cisplatin suspension in lipiodol (LPS) of hepatocellular carcinoma (I)--Preparation of LPS and its anticancer effect on a rabbit liver cancer model after injection into the hepatic artery].
Fukushima S; Kishimoto S; Hayashi Y; Kaneko M; Nakano M; Shibata J; Fujiyama S; Sato T
Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2743-9. PubMed ID: 2854837
[No Abstract] [Full Text] [Related]
38. Selective anticancer effects of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine, a lipophilic prodrug of 5-fluoro-2'-deoxyuridine, dissolved in an oily lymphographic agent on hepatic cancer of rabbits bearing VX-2 tumor.
Fukushima S; Kawaguchi T; Nishida M; Juni K; Yamashita Y; Takahashi M; Nakano M
Cancer Res; 1987 Apr; 47(7):1930-4. PubMed ID: 3028618
[TBL] [Abstract][Full Text] [Related]
39. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis.
Hanada M; Baba A; Tsutsumishita Y; Noguchi T; Yamaoka T; Chiba N; Nishikaku F
Cancer Chemother Pharmacol; 2009 Aug; 64(3):473-83. PubMed ID: 19104812
[TBL] [Abstract][Full Text] [Related]
40. Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.
Zhang L; Liu FY; Fu JX; Duan F; Fan QS; Wang MQ
Int J Clin Exp Pathol; 2014; 7(11):7775-81. PubMed ID: 25550815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
